With thoughtfully designed spaces and guest experiences focused on connection, Crowne Plaza remains a top choice for hybrid travellers in the Middle East DUBAI, UAE, May 12, 2025 /PRNewswire/ -- Crowne Plaza by IHG – one of the world's largest premium hotel brands and a thought-leader in the blended travel space – has released its second white paper: Leading the Charge in Blended Travel . The report unveils a major shift since its 2022 report, driven by a new breed of companies and individuals seeking far-reaching flexibility that extends beyond traditional work-life balance and into a holistic approach focused on …

BIRMINGHAM, Ala., May 12, 2025 (GLOBE NEWSWIRE) -- Diversified Energy Company PLC (LSE: DEC, NYSE:DEC) (“Diversified” or “the Company”) is pleased to announce that the Board has declared an interim dividend of 29 cents per share in respect of 1Q25 for the three month period ended March 31, 2025.

PARIS and CAMBRIDGE, Mass., May 12, 2025 (GLOBE NEWSWIRE) -- NANOBIOTIX (Euronext: NANO –– NASDAQ: NBTX – the ‘‘Company''), a late-clinical stage biotechnology company pioneering nanoparticle-based approaches to expand treatment possibilities for patients with cancer and other major diseases, announced today that Company management will participate in fireside chats at following conference:

Schwab Emerging Markets Equity ETF benefits from a weaker U.S. dollar and relatively stable commodity prices. Elevated U.S. interest rates remain a headwind, though some emerging economies are more resilient. SCHE is heavily concentrated in Asia, with significant exposure to China and India.

Iovance Biotherapeutics' stock plummeted 45% after a Q1 earnings miss, driven by temporary manufacturing issues and reduced revenue guidance. Management expects a rebound in Q2 with resumed full manufacturing capacity and increased commercial infusions, potentially leading to a positive earnings surprise. Despite the Q1 setback, Iovance's early adoption, expanding treatment network, and international regulatory prospects indicate strong long-term growth potential.

A list of high-quality dividend-growth stocks trading near 52-week lows is evaluated based on historical and future fair values. Alphabet's strong financials, attractive historical valuations, and promising future growth make it a compelling investment, despite concerns about AI competition and DOJ scrutiny. Other potentially attractively valued dividend growth stocks include United Parcel Service, Merck, Pfizer, UnitedHealth Group, PepsiCo, Bristol-Myers Squibb, Qualcomm, Elevance Health, A. O. Smith, and Chevron.

Tewksbury, Massachusetts--(Newsfile Corp. - May 12, 2025) - Atamian Honda, one of Massachusetts' most respected and enduring automotive dealerships, proudly announces the celebration of its 50th anniversary. Since opening its doors in 1976, the dealership-located at 150 Main Street in Tewksbury-has become a trusted name for generations of car buyers, offering top-tier service, a wide selection of vehicles, and a deep commitment to the community it calls home.

Paris, May 12 , 2025 - Jeito Capital (“Jeito”), a global leading independent Private Equity fund dedicated to biopharma, is pleased to announce the promotion of Mehdi Ainouche to Partner and Julien Elric to Senior Principal.

Saint Herblain (France), May, 12 2025 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that the U.S. Food and Drug Association (FDA) and the U.S. Centers for Disease Control and Prevention (CDC), in a joint communication to the medical community, have recommended a pause in the use of Valneva's single-dose live attenuated chikungunya vaccine IXCHIQ® in elderly individuals while ongoing investigations into reported serious adverse events (SAEs) are completed. This update follows an earlier recommendation from the U.S. Advisory Committee on Immunization Practices (ACIP) to include a precaution related to the use of IXCHIQ® …

Ad Hoc Announcement Pursuant to Art. 53 LR Geneva, Switzerland, May 12, 2025 - Addex Therapeutics (SIX/NASDAQ: ADXN), a clinical-stage biopharmaceutical company focused on developing a portfolio of novel small molecule allosteric modulators for neurological disorders, announced today partner Indivior has successfully advanced its GABAB positive allosteric modulator (PAM) program through IND enabling studies.

Vancouver, British Columbia and Johannesburg, South Africa--(Newsfile Corp. - May 12, 2025) - Platinum Group Metals Ltd. (TSX: PTM) (NYSE American: PLG) ("Platinum Group" or the "Company") reports that it intends, subject to regulatory approval, to sell 800,000 common shares of the Company at price of US$1.26 each for gross proceeds of US$1,008,000 million (the "Private Placement") to existing major beneficial shareholder, Hosken Consolidated Investments Limited ("HCI").

Investors may have been agonizing over trades in recent months but this AI trader has a clear plan—for better or worse.

SCHD has become a popular ETF because its energy and consumer staple dividend stocks are seen as relatively safe, amid the current market uncertainty. Unfortunately, the perception here is largely incorrect. SCHD's energy stocks import oil from Canada, and consumer staples in general are heavily involved in importing and exporting. Foreign stocks and financials are more interesting right now than U.S. consumer staples.

Permian Resources is a solid buy due to resilient Q1 results, strong production figures, and a nearly 7% yield, despite oil price headwinds. Technical analysis shows a potential breakout from the long-term downtrend, supported by bullish moving averages and indicators. The stock's P/S ratio contraction suggests undervaluation, making it attractive given the company's robust operational growth and strategic acquisitions.

Nomura's Rob Subbaraman warns of looming pressure on ASEAN industries as China redirects exports amid fracturing trade relations with the U.S.

GFL Environmental has significantly reduced its leverage, improving its financial stability and making it more attractive to investors, with a stock up ~15% YTD. The company's aggressive growth strategy, including frequent acquisitions and organic growth, targets $9.24-9.49B in annual revenue by 2028. Despite lower current margins compared to peers, GFL's strategic investments in renewable natural gas and recycling automation are expected to enhance profitability over the next few years.

Bloomin' Brands stock fell over 8% despite beating EPS and revenue estimates due to weak Q2 guidance and declining same-store sales. Outback Steakhouse's performance is crucial for Bloomin's recovery, but it continues to struggle with negative same-store sales and losing market share. Management's value strategies, including menu cuts and promotions, haven't improved sales, leading to a cautious 'Hold' rating with a price target of $7–$8.

SVOL's original strategy of shorting the VIX has failed due to sustained high volatility, leading to negative returns and heightened risks for investors. The fund has pivoted to a new, incoherent strategy involving leveraged S&P 500 futures and options, which carries significant downside risks. Current economic and political uncertainties, including the US-China trade conflict and mixed Fed signals, are likely to maintain high volatility levels.

Gold and silver prices remain in correction mode, and support is sought for the next move.

Boston Beer's Q1 sales were very strong due to great shipments, but the underlying performance was also resilient. Sales should remain good with Sun Cruiser's rollout and Twisted Tea's resilience. The gross margin has continued to recover significantly despite continued shortfall fees and non-cash pre-payments. Despite tariff pressure, Boston Beer should continue to gain margin. Boston Beer's stock remains moderately overvalued. I estimate a fair value of $210.9.